Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Latest Thalidomide Stories

2014-03-27 08:35:29

DUBLIN, Mar. 27, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/48gc9x/therapeutic_class ) has announced the addition of the "Therapeutic Class Overview: Treating Refractory Hematological Malignancies" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) Targeting unmet needs in the treatment of cancer/ hematological malignancies through innovative drug development strategies have witnessed favorable...

2014-02-06 16:27:04

Unsealed federal lawsuit alleges that pharmaceutical giant engaged in unlawful marketing schemes involving blockbuster drugs Thalomid and Revlimid in cancer treatment, costing taxpayers hundreds of millions of dollars; charges of kickbacks to physicians in pushing for unapproved treatments LOS ANGELES and WASHINGTON, Feb. 6, 2014 /PRNewswire/ -- Leading whistleblower law firm Grant & Eisenhofer P.A. represents a key whistleblower in a false claims lawsuit unsealed today against...

2013-11-27 15:06:57

Among children and adolescents with Crohn disease not responding to treatment, use of the drug thalidomide resulted in improved clinical remission after 8 weeks of treatment compared with placebo, according to a study appearing in the November 27 issue of JAMA. As many as 1.2 million people in Europe and more than half a million in the United States are estimated to have Crohn disease, a chronic inflammatory disease involving the digestive system. Its incidence is increasing globally....

2013-09-26 23:19:52

Reportbuyer.com just published a new market research report: Orphan Drugs for Cancer: R&D and Market 2013-2023. London (PRWEB) September 26, 2013 Report Details Orphan cancer drugs - new study shows you trends, R&D, and sales forecasts What's the future of orphan medicines to treat cancers? Visiongain's new report gives you revenue predictions from 2013. There you explore results, R&D, opportunities, and potential sales. Orphan drugs can be profitable. In our analysis...

2013-06-13 15:59:06

Problem is worsening; time to include pregnant women in drug trials, says DTB The lack of hard data on the safety and effectiveness of a wide range of drugs in pregnancy has hindered the treatment of pregnant women, contributing to a doubling of deaths amongst mums-to-be with an underlying health problem over the past 20 years, argues an editorial in the Drug and Therapeutics Bulletin (DTB). It's time to include pregnant women in drug trials so that they can get the medical treatment...

Did Western Drug Companies Subject East Germans To Wrongful Medical Trials?
2013-05-15 10:45:22

redOrbit Staff & Wire Reports - Your Universe Online Western drug companies tested pharmaceuticals on more than 50,000 people in the former communist East Germany, several of whom died, the German weekly Der Spiegel reported this week, according to BBC News and other media outlets. Some 600 clinical trials were allegedly conducted in more than 50 hospitals until the 1989 fall of the Berlin Wall, according to the report, which cited previously unpublished documents that came from...

2013-01-25 10:23:12

Researchers at Moffitt Cancer Center and colleagues have investigated the safety, efficacy and the maximum tolerated dose of pomalidomide for patients with multiple myeloma who have disease relapsed after treatments with other drugs, such as bortezomib and lenalidomide.  This phase I clinical trial enrolled 38 patients, and pomalidomide provided a minimal or better response for 42 percent of the patients, a partial response or better for 21 percent, and a complete response for 3 percent....

2012-11-06 03:51:36

Special issue honors Frances O. Kelsey, pioneer in drug safety and regulation Pharmaceutical health services research goes beyond studying the effects of individual drugs, to looking at the complex and interrelated effects of medications on the health of patients and the population. The special November issue of Medical Care highlights important new papers in key areas of pharmaceutical health services research. The journal is published by Lippincott Williams & Wilkins, a part of...

2012-10-11 11:26:42

WASHINGTON, Oct. 11, 2012 /PRNewswire/ -- The Food and Drug Administration Alumni Association (FDAAA) received The Frances O. Kelsey Award for Excellence and Courage in Protecting the Public Health at an October 2 FDA ceremony marking the 50(th) anniversary of the passage of the 1962 Kefauver-Harris Amendments to the 1938 Federal Food, Drug, and Cosmetic Act. (Photo: http://photos.prnewswire.com/prnh/20121011/PH91353-a ) (Photo: http://photos.prnewswire.com/prnh/20121011/PH91353-b )...

2012-09-18 18:40:31

In the first clinical trial to demonstrate an effective treatment for constant, disabling cough among people with idiopathic pulmonary fibrosis (IPF), researchers at the Johns Hopkins University School of Medicine found that taking thalidomide significantly reduced the cough and improved quality of life. Results of their study are scheduled to be published in the Annals of Internal Medicine on Sept. 18 in an article titled "Thalidomide for the Treatment of Cough in Idiopathic Pulmonary...